CDLX SEC Filing News — Cardlytics, Inc.

Latest SEC filings for Cardlytics, Inc. (CDLX) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-10-02.

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company provides Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data from merchant data partners, including product-level purchase data to enable marketers to…
Sector: Communication Services Industry: Advertising Agencies Market Cap: $10.8M CIK: 1666071
20
Total Filings
0
Bullish Classifications
4
Bearish Classifications
9
Insider Transactions
3
Material Events (8-K)
1
Periodic Reports
Rule-based classifications for CDLX currently lean bearish. Of the 20 filing records displayed, 4 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.
CDLX Filing Activity Snapshot 2026-05-21 — 2026-10-02
Insider Transactions (Form 4)
0 buys vs 4 sells
Net insider selling in this period — insiders sell for many reasons beyond conviction.
Largest Form 144 Filing
$70.9K
Gupta Amit (Director, Chief Executive Officer) · 2026-07-06
16,138 shares · Form 4
Form 144 Notices
7
Proposed insider sales filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.
Insider Transactions 9 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 9 filings in this group are Form 4s for Cardlytics, Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 9 insider filings shown, the breakdown is 5 compensation award and 4 open-market sale. 4 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Compensation award ×5
Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Open-market sale ×4
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Form 4 Open-market sale Insider Selling 2026-10-02

CDLX insider Gupta Amit (Director, Chief Executive Officer) sold 17,733 shares (~$46.7K)

Gupta Amit, listed as Director, Chief Executive Officer at Cardlytics, Inc., reported an open-market sale of 17,733 CDLX shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 18,750 — —
M Option exercise 12,500 — —
S Open-market sale 10,351 $2.71 $28.1K
S Open-market sale 7,382 $2.53 $18.7K
M Option exercise derivative · Restricted Stock Units 18,750 — —
M Option exercise derivative · Restricted Stock Unit 12,500 — —
Filing: Form 4 (Insider Transaction) Insider: Gupta Amit (Director, Chief Executive Officer) Shares: 17,733 Est. Value: $46.7K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-08-18

CDLX insider Gupta Amit (Director, Chief Executive Officer) sold 13,461 shares (~$53.8K)

Gupta Amit, listed as Director, Chief Executive Officer at Cardlytics, Inc., reported an open-market sale of 13,461 CDLX shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 12,500 — —
M Option exercise 12,500 — —
S Open-market sale 6,785 $3.97 $26.9K
S Open-market sale 6,676 $4.03 $26.9K
M Option exercise derivative · Restricted Stock Units 12,500 — —
M Option exercise derivative · Restricted Stock Units 12,500 — —
Filing: Form 4 (Insider Transaction) Insider: Gupta Amit (Director, Chief Executive Officer) Shares: 13,461 Est. Value: $53.8K
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-08-04

CDLX insider Form 4 filed for equity award, exercise, or tax withholding

Cheng Christopher Chi-Kit (Chief Legal & Privacy Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Restricted Stock Units 50,000 — —
Filing: Form 4 (Insider Transaction) Insider: Cheng Christopher Chi-Kit (Chief Legal & Privacy Officer)
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-07-06

CDLX insider Gupta Amit (Director, Chief Executive Officer) sold 16,138 shares (~$70.9K)

Gupta Amit, listed as Director, Chief Executive Officer at Cardlytics, Inc., reported an open-market sale of 16,138 CDLX shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 12,500 — —
M Option exercise 18,750 — —
S Open-market sale 6,498 $4.39 $28.6K
S Open-market sale 9,640 $4.39 $42.4K
M Option exercise derivative · Restricted Stock Units 12,500 — —
M Option exercise derivative · Restricted Stock Units 18,750 — —
Filing: Form 4 (Insider Transaction) Insider: Gupta Amit (Director, Chief Executive Officer) Shares: 16,138 Est. Value: $70.9K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-07-06

CDLX insider Lynton Nicholas Hollmeyer (Chief Legal & Privacy Officer) sold 2,151 shares (~$9.5K)

Lynton Nicholas Hollmeyer, listed as Chief Legal & Privacy Officer at Cardlytics, Inc., reported an open-market sale of 2,151 CDLX shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 157 — —
M Option exercise 1,500 — —
M Option exercise 312 — —
M Option exercise 2,750 — —
S Open-market sale 2,151 $4.39 $9.5K
M Option exercise derivative · Restricted Stock Units 157 — —
M Option exercise derivative · Restricted Stock Units 1,500 — —
M Option exercise derivative · Restricted Stock Units 312 — —
M Option exercise derivative · Restricted Stock Unit 2,750 — —
Filing: Form 4 (Insider Transaction) Insider: Lynton Nicholas Hollmeyer (Chief Legal & Privacy Officer) Shares: 2,151 Est. Value: $9.5K
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-05-21

CDLX insider Form 4 filed for equity award, exercise, or tax withholding

Gupta Srishti A. (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 11,000 — —
A Compensation award derivative · Restricted Stock Unit 11,000 — —
M Option exercise derivative · Restricted Stock Units 11,000 — —
Filing: Form 4 (Insider Transaction) Insider: Gupta Srishti A. (Director) Shares: 11,000
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-05-21

CDLX insider Form 4 filed for equity award, exercise, or tax withholding

Francis Jonathan Edward (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 11,000 — —
A Compensation award derivative · Restricted Stock Units 11,000 — —
M Option exercise derivative · Restricted Stock Units 11,000 — —
Filing: Form 4 (Insider Transaction) Insider: Francis Jonathan Edward (Director) Shares: 11,000
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-05-21

CDLX insider Form 4 filed for equity award, exercise, or tax withholding

Hill Scott A (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 11,000 — —
A Compensation award derivative · Restricted Stock Unit 11,000 — —
M Option exercise derivative · Restricted Stock Units 11,000 — —
Filing: Form 4 (Insider Transaction) Insider: Hill Scott A (Director) Shares: 11,000
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-05-21

CDLX insider Form 4 filed for equity award, exercise, or tax withholding

Fernandez Andre J (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 11,000 — —
A Compensation award derivative · Restricted Stock Units 11,000 — —
M Option exercise derivative · Restricted Stock Units 11,000 — —
Filing: Form 4 (Insider Transaction) Insider: Fernandez Andre J (Director) Shares: 11,000
View on SEC EDGAR → Open Filing Document →
Proposed Insider Sales 7 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. Cardlytics, Inc. has 7 such notices in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-10-02

CDLX Form 144 filed for proposed insider sale by Gupta Amit (7,382 shares) ~$18.7K

Gupta Amit filed a Form 144 with the SEC indicating intent to sell CDLX (Cardlytics, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Gupta Amit Shares: 7,382 Est. Value: $18.7K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-10-01

CDLX Form 144 filed for proposed insider sale by Gupta Amit (10,351 shares) ~$28.1K

Gupta Amit filed a Form 144 with the SEC indicating intent to sell CDLX (Cardlytics, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Gupta Amit Shares: 10,351 Est. Value: $28.1K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-08-18

CDLX Form 144 filed for proposed insider sale by Gupta Amit (6,676 shares) ~$26.9K

Gupta Amit filed a Form 144 with the SEC indicating intent to sell CDLX (Cardlytics, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Gupta Amit Shares: 6,676 Est. Value: $26.9K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-08-17

CDLX Form 144 filed for proposed insider sale by Gupta Amit (6,785 shares) ~$26.9K

Gupta Amit filed a Form 144 with the SEC indicating intent to sell CDLX (Cardlytics, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Gupta Amit Shares: 6,785 Est. Value: $26.9K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-07-06

CDLX Form 144 filed for proposed insider sale by Gupta Amit (9,640 shares) ~$42.4K

Gupta Amit filed a Form 144 with the SEC indicating intent to sell CDLX (Cardlytics, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Gupta Amit Shares: 9,640 Est. Value: $42.4K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-07-02

CDLX Form 144 filed for proposed insider sale by Gupta Amit (6,498 shares) ~$28.6K

Gupta Amit filed a Form 144 with the SEC indicating intent to sell CDLX (Cardlytics, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Gupta Amit Shares: 6,498 Est. Value: $28.6K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-07-02

CDLX Form 144 filed for proposed insider sale by Lynton Nicholas Hollmeyer (2,151 shares) ~$9.5K

Lynton Nicholas Hollmeyer filed a Form 144 with the SEC indicating intent to sell CDLX (Cardlytics, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Lynton Nicholas Hollmeyer Shares: 2,151 Est. Value: $9.5K
View on SEC EDGAR → Open Filing Document →
Material Events 3 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 3 in this period for Cardlytics, Inc. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-09-11

CDLX filed 8-K — material company event

Cardlytics, Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-08-05

CDLX filed 8-K — material company event

Cardlytics, Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-06-03

CDLX filed 8-K — material company event

Cardlytics, Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Periodic Reports 1 · Forms 10-K and 10-Q

The periodic reports are where the audited and reviewed financial statements live. This period contains 1 quarterly report (10-Q) for Cardlytics, Inc.

The two are not equivalent in weight. A 10-K is audited by an external firm and includes the full risk factor disclosure, business description and management discussion; a 10-Q is unaudited, reviewed rather than examined, and much shorter. When a figure in a quarterly report is later revised, the annual report is usually where the correction appears.

An amended report — 10-K/A or 10-Q/A — restates or corrects something in the original filing, and is worth reading against the version it replaces.

Form 10-Q Quarterly Report 2026-08-05

CDLX filed Quarterly Report (10-Q)

Cardlytics, Inc. filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)
View on SEC EDGAR → Open Filing Document →

How we classify Cardlytics, Inc.'s filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on CDLX. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — CDLX SEC Filings

More Tools for CDLX

CDLX Full Stock Analysis CDLX Live Chart Institutional Ownership Earnings Calendar Options Flow Scanner Semiconductor Demand Zone Tracker Sector Scanner Browse All Stocks

Want deeper CDLX analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the CDLX stock analysis page.

CDLX Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer